|
||||||
Executive Summary Summary Oxford Biodynamics Plc (Oxford Biodynamics) is a developer of biomarker discovery platform. The company concentrates on research in detection, monitoring and prognosis of major diseases associated with aberrant gene expression such as oncology, metabolic, inflammatory, cardiovascular and neurodegenerative conditions. Its biomarker discovery platform is used for the detection of aberrant gene expression. The company's products are used in the areas of breast cancer diagnostics, hepatocellular carcinoma diagnostics, nasopharyngeal carcinoma diagnostics, prostate cancer progression, melanoma diagnostics, and age related disease diagnostics. Oxford Bio is headquartered in Oxford, Oxfordshire, the UK. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Scope: - The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments - The report analyzes all pipeline products in development for the company Oxford Biodynamics Plc - The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) - The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date - The report provides detailed description of products in development, technical specification and functions - The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date. Reasons to Buy: - Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape - Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio - To formulate effective Research & Development strategies - Develop market-entry and market expansion strategies - Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc - Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio Note: Some sections may be missing if data is unavailable for the company Read More Contact Us:
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 5 Oxford Biodynamics Plc Company Overview 6 Oxford Biodynamics Plc Company Snapshot 6 Oxford Biodynamics Plc Pipeline Products and Ongoing Clinical Trials Overview 6 Oxford Biodynamics Plc-Pipeline Analysis Overview 9 Oxford Biodynamics Plc-Key Facts 9 Oxford Biodynamics Plc-Major Products and Services 10 Oxford Biodynamics Plc Pipeline Products by Development Stage 11 Oxford Biodynamics Plc Pipeline Products Overview 16 Companion Diagnostic Test-Amyotrophic Lateral Sclerosis 16 Companion Diagnostic Test-Amyotrophic Lateral Sclerosis Product Overview 16 Companion Diagnostic Test-Corticobasal Degeneration 17 Companion Diagnostic Test-Corticobasal Degeneration Product Overview 17 Companion Diagnostic Test-Dementia With Lewy Bodies 18 Companion Diagnostic Test-Dementia With Lewy Bodies Product Overview 18 Companion Diagnostic Test-Diffuse Lewy Body Disease 19 Companion Diagnostic Test-Diffuse Lewy Body Disease Product Overview 19 Companion Diagnostic Test-Frontotemporal Lobar Degeneration 20 Companion Diagnostic Test-Frontotemporal Lobar Degeneration Product Overview 20 Companion Diagnostic Test-Multiple System Atrophy 21 Companion Diagnostic Test-Multiple System Atrophy Product Overview 21 Companion Diagnostic Test-Osteoporosis 22 Companion Diagnostic Test-Osteoporosis Product Overview 22 Companion Diagnostic Test-Parkinsonism-Dementia-Amyotrophic Lateral Sclerosis Complex 23 Companion Diagnostic Test-Parkinsonism-Dementia-Amyotrophic Lateral Sclerosis Complex Product Overview 23 Companion Diagnostic Test-Progressive Supranuclear Palsy 24 Companion Diagnostic Test-Progressive Supranuclear Palsy Product Overview 24 Companion Diagnostic Test-Sarcopenia 25 Companion Diagnostic Test-Sarcopenia Product Overview 25 EpiSwitch Alzheimer's Disease Diagnostic Test 26 EpiSwitch Alzheimer's Disease Diagnostic Test Product Overview 26 EpiSwitch Biomarker-Concussion 27 EpiSwitch Biomarker-Concussion Product Overview 27 EpiSwitch Breast Cancer Test 28 EpiSwitch Breast Cancer Test Product Overview 28 EpiSwitch Diagnostic Assay-Amyotrophic Lateral Sclerosis 29 EpiSwitch Diagnostic Assay-Amyotrophic Lateral Sclerosis Product Overview 29 EpiSwitch Diffuse Large B-Cell Lymphoma Test 30 EpiSwitch Diffuse Large B-Cell Lymphoma Test Product Overview 30 EpiSwitch Liver Cancer Test 31 EpiSwitch Liver Cancer Test Product Overview 31 EpiSwitch Melanoma Companion Diagnostic Assay 32 EpiSwitch Melanoma Companion Diagnostic Assay Product Overview 32 EpiSwitch Melanoma Test 33 EpiSwitch Melanoma Test Product Overview 33 EpiSwitch Melanoma Test-Prognosis 34 EpiSwitch Melanoma Test-Prognosis Product Overview 34 EpiSwitch Melanoma Test-Residual Disease Monitoring 35 EpiSwitch Melanoma Test-Residual Disease Monitoring Product Overview 35 EpiSwitch Nasopharyngeal Cancer Test 36 EpiSwitch Nasopharyngeal Cancer Test Product Overview 36 EpiSwitch Parkinson's Disease Diagnostic Test 37 EpiSwitch Parkinson's Disease Diagnostic Test Product Overview 37 EpiSwitch Primary Progressive Multiple Sclerosis Test 38 EpiSwitch Primary Progressive Multiple Sclerosis Test Product Overview 38 EpiSwitch Prognostic Assay-Amyotrophic Lateral Sclerosis 39 EpiSwitch Prognostic Assay-Amyotrophic Lateral Sclerosis Product Overview 39 EpiSwitch Prognostic Assay-Tyrosine Kinase Inhibitors 40 EpiSwitch Prognostic Assay-Tyrosine Kinase Inhibitors Product Overview 40 EpiSwitch Prostate Cancer Prognostic Assay 41 EpiSwitch Prostate Cancer Prognostic Assay Product Overview 41 EpiSwitch Prostate Cancer Test 42 EpiSwitch Prostate Cancer Test Product Overview 42 EpiSwitch Relapsing Remitting Multiple Sclerosis Test 43 EpiSwitch Relapsing Remitting Multiple Sclerosis Test Product Overview 43 EpiSwitch Rheumatoid Arthritis Predictive Biomarker Test 44 EpiSwitch Rheumatoid Arthritis Predictive Biomarker Test Product Overview 44 EpiSwitch Systemic Lupus Erythematosus Prognostic Test 45 EpiSwitch Systemic Lupus Erythematosus Prognostic Test Product Overview 45 EpiSwitch T1DM Diagnostic Test 46 EpiSwitch T1DM Diagnostic Test Product Overview 46 EpiSwitch T1DM Prognostic Test 47 EpiSwitch T1DM Prognostic Test Product Overview 47 EpiSwitch T2DM Prognostic Test 48 EpiSwitch T2DM Prognostic Test Product Overview 48 EpiSwitch Thyroid Cancer Diagnostic Test 49 EpiSwitch Thyroid Cancer Diagnostic Test Product Overview 49 EpiSwitch Ulcerative Colitis Test 50 EpiSwitch Ulcerative Colitis Test Product Overview 50 Oxford Biodynamics Plc-Key Competitors 51 Oxford Biodynamics Plc-Key Employees 52 Oxford Biodynamics Plc-Locations And Subsidiaries 53 Head Office 53 Other Locations & Subsidiaries 53 Recent Developments 54 Oxford Biodynamics Plc, Recent Developments 54 Jul 19, 2018: Oxford BioDynamics announces grant of Canadian patent for its proprietary technology platform, EpiSwitch 54 Jul 17, 2018: OBD presents latest data on the use of EpiSwitch in predicting patient response to immunotherapy and identifying lymphoma subtypes 54 Jun 26, 2018: Study published in peer reviewed journal identifies EpiSwitch biomarker for the diagnosis of Amyotrophic Lateral Sclerosis 55 May 22, 2018: Oxford Biodynamics: Interim Results For The Six-Month Period Ended 31 March 2018 55 Mar 28, 2018: Study published in Journal of Translational Medicine demonstrates predictive power of EpiSwitch to identify inadequate response to methotrexate in early rheumatoid arthritis 56 Mar 16, 2018: OBD presents latest ALS biomarker data at the 6th World CNS Summit (Targeting Neurodegenerative Diseases) 57 Feb 14, 2018: Oxford BioDynamics announces grant of Indian patent for its proprietary technology platform, EpiSwitch 58 Nov 15, 2017: Oxford BioDynamics presents latest immunotherapy data at the NIH Biomarker Consortium Cancer Steering Committee Annual Symposium, in Washington, DC 58 Oct 13, 2017: Oxford BioDynamics presents at the Diabetes Asia 2017 Conference 59 Oct 13, 2017: Oxford BioDynamics presents at the Diabetes Asia 2017 Conference 60 Appendix 61 Methodology 61 About GlobalData 64 Contact Us 64 Disclaimer 64 List of Figures Oxford Biodynamics Plc Pipeline Products by Equipment Type 7 Oxford Biodynamics Plc Pipeline Products by Development Stage 11 List of Tables Oxford Biodynamics Plc Pipeline Products and Ongoing Clinical Trials Overview 6 Oxford Biodynamics Plc Pipeline Products by Equipment Type 7 Oxford Biodynamics Plc Pipeline Products by Indication 8 Oxford Biodynamics Plc, Key Facts 9 Oxford Biodynamics Plc, Major Products and Services 10 Oxford Biodynamics Plc Number of Pipeline Products by Development Stage 11 Oxford Biodynamics Plc Pipeline Products Summary by Development Stage 12 Companion Diagnostic Test-Amyotrophic Lateral Sclerosis-Product Status 16 Companion Diagnostic Test-Amyotrophic Lateral Sclerosis-Product Description 16 Companion Diagnostic Test-Corticobasal Degeneration-Product Status 17 Companion Diagnostic Test-Corticobasal Degeneration-Product Description 17 Companion Diagnostic Test-Dementia With Lewy Bodies-Product Status 18 Companion Diagnostic Test-Dementia With Lewy Bodies-Product Description 18 Companion Diagnostic Test-Diffuse Lewy Body Disease-Product Status 19 Companion Diagnostic Test-Diffuse Lewy Body Disease-Product Description 19 Companion Diagnostic Test-Frontotemporal Lobar Degeneration-Product Status 20 Companion Diagnostic Test-Frontotemporal Lobar Degeneration-Product Description 20 Companion Diagnostic Test-Multiple System Atrophy-Product Status 21 Companion Diagnostic Test-Multiple System Atrophy-Product Description 21 Companion Diagnostic Test-Osteoporosis-Product Status 22 Companion Diagnostic Test-Osteoporosis-Product Description 22 Companion Diagnostic Test-Parkinsonism-Dementia-Amyotrophic Lateral Sclerosis Complex-Product Status 23 Companion Diagnostic Test-Parkinsonism-Dementia-Amyotrophic Lateral Sclerosis Complex-Product Description 23 Companion Diagnostic Test-Progressive Supranuclear Palsy-Product Status 24 Companion Diagnostic Test-Progressive Supranuclear Palsy-Product Description 24 Companion Diagnostic Test-Sarcopenia-Product Status 25 Companion Diagnostic Test-Sarcopenia-Product Description 25 EpiSwitch Alzheimer's Disease Diagnostic Test-Product Status 26 EpiSwitch Alzheimer's Disease Diagnostic Test-Product Description 26 EpiSwitch Biomarker-Concussion-Product Status 27 EpiSwitch Biomarker-Concussion-Product Description 27 EpiSwitch Breast Cancer Test-Product Status 28 EpiSwitch Breast Cancer Test-Product Description 28 EpiSwitch Diagnostic Assay-Amyotrophic Lateral Sclerosis-Product Status 29 EpiSwitch Diagnostic Assay-Amyotrophic Lateral Sclerosis-Product Description 29 EpiSwitch Diffuse Large B-Cell Lymphoma Test-Product Status 30 EpiSwitch Diffuse Large B-Cell Lymphoma Test-Product Description 30 EpiSwitch Liver Cancer Test-Product Status 31 EpiSwitch Liver Cancer Test-Product Description 31 EpiSwitch Melanoma Companion Diagnostic Assay-Product Status 32 EpiSwitch Melanoma Companion Diagnostic Assay-Product Description 32 EpiSwitch Melanoma Test-Product Status 33 EpiSwitch Melanoma Test-Product Description 33 EpiSwitch Melanoma Test-Prognosis-Product Status 34 EpiSwitch Melanoma Test-Prognosis-Product Description 34 EpiSwitch Melanoma Test-Residual Disease Monitoring-Product Status 35 EpiSwitch Melanoma Test-Residual Disease Monitoring-Product Description 35 EpiSwitch Nasopharyngeal Cancer Test-Product Status 36 EpiSwitch Nasopharyngeal Cancer Test-Product Description 36 EpiSwitch Parkinson's Disease Diagnostic Test-Product Status 37 EpiSwitch Parkinson's Disease Diagnostic Test-Product Description 37 EpiSwitch Primary Progressive Multiple Sclerosis Test-Product Status 38 EpiSwitch Primary Progressive Multiple Sclerosis Test-Product Description 38 EpiSwitch Prognostic Assay-Amyotrophic Lateral Sclerosis-Product Status 39 EpiSwitch Prognostic Assay-Amyotrophic Lateral Sclerosis-Product Description 39 EpiSwitch Prognostic Assay-Tyrosine Kinase Inhibitors-Product Status 40 EpiSwitch Prognostic Assay-Tyrosine Kinase Inhibitors-Product Description 40 EpiSwitch Prostate Cancer Prognostic Assay-Product Status 41 EpiSwitch Prostate Cancer Prognostic Assay-Product Description 41 EpiSwitch Prostate Cancer Test-Product Status 42 EpiSwitch Prostate Cancer Test-Product Description 42 EpiSwitch Relapsing Remitting Multiple Sclerosis Test-Product Status 43 EpiSwitch Relapsing Remitting Multiple Sclerosis Test-Product Description 43 EpiSwitch Rheumatoid Arthritis Predictive Biomarker Test-Product Status 44 EpiSwitch Rheumatoid Arthritis Predictive Biomarker Test-Product Description 44 EpiSwitch Systemic Lupus Erythematosus Prognostic Test-Product Status 45 EpiSwitch Systemic Lupus Erythematosus Prognostic Test-Product Description 45 EpiSwitch T1DM Diagnostic Test-Product Status 46 EpiSwitch T1DM Diagnostic Test-Product Description 46 EpiSwitch T1DM Prognostic Test-Product Status 47 EpiSwitch T1DM Prognostic Test-Product Description 47 EpiSwitch T2DM Prognostic Test-Product Status 48 EpiSwitch T2DM Prognostic Test-Product Description 48 EpiSwitch Thyroid Cancer Diagnostic Test-Product Status 49 EpiSwitch Thyroid Cancer Diagnostic Test-Product Description 49 EpiSwitch Ulcerative Colitis Test-Product Status 50 EpiSwitch Ulcerative Colitis Test-Product Description 50 Oxford Biodynamics Plc, Key Employees 52 Oxford Biodynamics Plc, Other Locations 53 Glossary 63 Single User License: Site License: Corporate User License: LGC Ltd InHealth Almac Discovery Ltd Aktogen Ltd ABS Laboratories Ltd Oxford Biodynamics Plc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies |
select a license |
||
NEWSLETTER BY CATEGORY
|
||
Testimonials
|
||
The report was very informative and gives me an interesting view on the Indian market.... "Area Sales Manager, Muhlen Sohn GmbH & Co. KG"We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help... "Group Vice President Strategy, Aliaxis"I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again... "Technical Marketing Manager, Ascendis Health Limited"I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ... "., Coldwell Banker - Riyadh "The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future... "International and Business Dev. Director, Duta Abadi Primantara" |